C2C Stock Financial Analysis - Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) (DB) Stock

Overview

Concord Medical Services Holdings Limited is a healthcare company based in China, primarily engaged in operating a network of radiotherapy and diagnostic imaging centers throughout the country. As a leader in the Chinese healthcare sector, Concord Medical focuses on providing top-notch cancer treatment and diagnostic services, including managing the China-based operations of the renowned MD Anderson Cancer Center. A key project for Concord Medical includes its investment and development in the construction of specialty cancer hospitals in several Chinese cities, aiming to significantly enhance cancer care infrastructure and expertise across the region. The company is committed to advancing oncological research and improving treatment accessibility, leveraging cutting-edge technology and collaborating with international partners to uplift standards of care.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is 383.96 MM.
The operating income for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -532.16 MM.
The net income for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -308.24 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2024-12-31	383.96	-532.16	-308.24
2024-09-30	427.83	-489.43	-343.59
2024-06-30	471.70	-446.70	-378.93
2024-03-31	504.55	-454.84	-338.29
2023-12-31	537.40	-462.99	-297.66
2023-09-30	574.87	-478.22	-381.83
2023-06-30	612.34	-493.46	-465.99
2023-03-31	542.21	-509.25	-477.83
2022-12-31	472.08	-525.05	-489.66
2022-09-30	454.55	-522.54	-392.70
2022-06-30	437.01	-520.03	-295.75
2022-03-31	461.32	-489.17	-283.59
2021-12-31	485.63	-458.32	-271.43
2021-09-30	409.26	-394.88	-271.48
2021-06-30	332.89	-331.44	-271.52
2021-03-31	277.95	-319.47	-290.76
2020-12-31	223.01	-307.50	-309.99
2020-09-30	202.44	-340.72	-302.86
2020-06-30
2020-03-31

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2024-12-31
2024-09-30
2024-06-30	-86.74	-86.74
2024-03-31	-77.44	-77.44
2023-12-31	-68.14	-68.14
2023-09-30	-87.41	-87.41
2023-06-30	-106.67	-106.69
2023-03-31	-109.38	-109.39
2022-12-31	-112.09	-112.09
2022-09-30	-152.75	-125.07
2022-06-30	-193.42	-138.05
2022-03-31	-190.64	-162.95
2021-12-31	-187.85	-187.85
2021-09-30	-165.94	-175.04
2021-06-30	-144.10	-162.26
2021-03-31	-148.72	-157.81
2020-12-31	-153.35	-153.35
2020-09-30	-139.03	-143.34
2020-06-30	-124.63	-133.27
2020-03-31	-125.95	-130.27

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -397.75 MM.
The cash from investing activities for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -593.44 MM.
The cash from financing activities for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is 1,146.03 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2024-12-31	-397.75	-593.44	1,146.03
2024-09-30
2024-06-30
2024-03-31
2023-12-31	-276.47	-47.68	257.65
2023-09-30
2023-06-30
2023-03-31
2022-12-31	-216.69	-118.79	383.09
2022-09-30
2022-06-30
2022-03-31
2021-12-31	-359.31	-565.98	642.45
2021-09-30
2021-06-30
2021-03-31
2020-12-31	-229.77	-533.88	1,138.30
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31

Management Effectiveness

The roa for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -0.06.
The roe for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -0.18.
The roic for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -0.07.
The croic for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is 0.00.
The ocroic for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is 0.00.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2024-12-31	-0.06	-0.18	-0.07	0.00	0.00
2024-09-30	-0.06	-0.20	-0.07	-0.01	-0.05
2024-06-30	-0.06	-0.16	-0.06	-0.01	-0.05
2024-03-31	-0.05	-0.15	-0.06	-0.01	-0.05
2023-12-31	-0.06	-0.19	-0.08	0.00	0.00
2023-09-30	-0.07	-0.19	-0.09	0.00	-0.04
2023-06-30	-0.07	-0.19	-0.09	0.00	-0.04
2023-03-31	-0.08	-0.19	-0.09	0.00	-0.04
2022-12-31	-0.06	-0.14	-0.07	0.00	0.00
2022-09-30	-0.06	-0.14	-0.07	-0.05	-0.07
2022-06-30	-0.05	-0.10	-0.05	-0.05	-0.06
2022-03-31	-0.05	-0.10	-0.05	-0.05	-0.06
2021-12-31	-0.05	-0.11	-0.05	-0.05	-0.07
2021-09-30	-0.05	-0.11	-0.05	0.07	-0.04
2021-06-30	-0.05	-0.11	-0.05	0.07	-0.04
2021-03-31	-0.05	-0.11	-0.05	0.07	-0.04
2020-12-31	-0.07	-0.16	-0.07	0.08	-0.05
2020-09-30	-0.07	-0.16	-0.06	-0.16	-0.04
2020-06-30	-0.07	-0.12	-0.06	-0.15	-0.04
2020-03-31	-0.07	-0.12	-0.06	-0.15	-0.04

Gross Margins

The gross margin for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -0.17.
The net margin for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -0.80.
The operating margin for Concord Medical Services Holdings Limited - Depositary Receipt (Common Stock) as of 31 December 2024 is -0.95.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2024-12-31	-0.17	-0.80	-0.95
2024-09-30	-0.17	-0.80	-0.95
2024-06-30	-0.16	-0.67	-0.90
2024-03-31	-0.14	-0.55	-0.86
2023-12-31	-0.15	-0.66	-0.83
2023-09-30	-0.17	-0.76	-0.81
2023-06-30	-0.17	-0.76	-0.81
2023-03-31	-0.23	-0.88	-0.94
2022-12-31	-0.33	-0.86	-1.15
2022-09-30	-0.33	-0.86	-1.15
2022-06-30	-0.34	-0.68	-1.19
2022-03-31	-0.22	-0.61	-1.06
2021-12-31	-0.12	-0.56	-0.94
2021-09-30	-0.05	-0.66	-0.96
2021-06-30	0.06	-0.82	-1.00
2021-03-31	0.06	-1.05	-1.15
2020-12-31	0.06	-1.39	-1.38
2020-09-30	-0.02	-1.50	-1.68
2020-06-30	-0.12	-1.63	-2.06
2020-03-31	-0.10	-1.59	-1.93